Celltrion Trimebutine Maleate Tablets

Adult dose

As Trimebutine maleate, 100-200mg is taken orally three times a day before meals. Adjust appropriately based on age and symptoms.

This medication contains lactose; therefore, it should not be used by patients with a genetic disorder that prevents the digestion of lactose. While taking this medication, gastrointestinal-related side effects such as constipation, diarrhea, abdominal sounds, nausea, vomiting, dyspepsia, dry mouth, and a feeling of numbness in the mouth may occur rarely. Additionally, symptoms related to the nervous system such as palpitations, fatigue, drowsiness, dizziness, lethargy, and headaches may also be experienced occasionally. Caution is necessary as liver enzyme levels may rise in relation to liver function. Allergic reactions such as skin rashes may occur due to this medication; therefore, treatment should be discontinued immediately if these symptoms develop. The safety of this medication during pregnancy has not been sufficiently confirmed, so women who are pregnant or may become pregnant should only take this medication when the benefits of treatment outweigh the risks. Women who are breastfeeding should also avoid taking this medication as its safety has not been established; if it must be taken, it is advisable to discontinue breastfeeding. Furthermore, this medication contains Yellow No. 4, so individuals allergic or hypersensitive to this component should use it with caution.

Mild side effects

• Constipation
• diarrhea
• borborygmi (intestinal gas sounds)
• nausea
• vomiting
• dyspepsia
• dry mouth
• oral numbness
• palpitations
• fatigue

This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container to ensure safe storage of the contents. Additionally, the medication should be kept away from excessively hot or cold places, ideally stored at room temperature between 1°C and 30°C.

Appearance

Pale yellow round tablet

Package unit

30 tablets/bottle, 300 tablets/bottle